Friday, April 9, 2021

FDA Approves Once-Daily Nonstimulant for Treatment of ADHD

https://alert.psychnews.org/2021/04/fda-approves-once-daily-nonstimulant.html?m=1

Selective norepinephrine reuptake inhibitor Qelbree (viloxazine extended-release)